VO2 max testing / CPET
VO2 max testing, delivered via cardiopulmonary exercise testing (CPET), measures maximal oxygen uptake and is one of the most consistently replicated predictors of all-cause mortality in exercise physiology literature, alongside being highly trainable through aerobic exercise at any age. It is the flagship biomarker in Peter Attia's longevity medicine framework. Atlas linkage is currently zero due to generic clinic-description language, with manual linkage planned. Evidence tier: well-evidenced.
What it is
VO2 max, maximal oxygen uptake, measures the greatest rate at which a person's body can take in, transport, and use oxygen during increasingly intense exercise, and is widely regarded in exercise physiology as the single best laboratory measure of cardiorespiratory fitness. It is typically measured through cardiopulmonary exercise testing (CPET), in which a subject exercises on a treadmill or stationary bike at progressively increasing intensity while wearing a mask that captures breath-by-breath oxygen consumption and carbon dioxide output, alongside continuous heart rate and, in clinical settings, ECG monitoring. Large cohort studies, building on the original Cooper Clinic research and extended through subsequent large-cohort analyses, have repeatedly found VO2 max to be one of the strongest predictors of all-cause mortality available in clinical medicine, in some analyses a stronger predictor than smoking status or hypertension. Unlike many mortality risk markers, VO2 max is also highly trainable at virtually any age through structured aerobic exercise, giving it a rare combination of strong predictive power and direct actionability. It has become the flagship biomarker in several prominent longevity medicine frameworks, most notably Peter Attia's, where improving VO2 max is treated as a primary, modifiable lever against age-related decline.
Who it is for
VO2 max testing is relevant to adults seeking a quantified, clinically grounded measure of cardiorespiratory fitness and mortality risk, including those starting or evaluating a structured exercise program, and patients with cardiovascular or pulmonary symptoms for whom CPET serves a diagnostic purpose. Within the longevity economy, it is most heavily used by performance-oriented clinics and coaching programs building exercise prescription around a measured baseline.
What to expect
A VO2 max test or full CPET is typically delivered as a single session, 20 to 45 minutes including warm-up and recovery, performed on a treadmill or cycle ergometer under the supervision of an exercise physiologist or physician, with a mask or mouthpiece capturing gas exchange data throughout a progressively harder protocol to volitional exhaustion. Clinical CPET settings add ECG and blood pressure monitoring for diagnostic purposes; performance-oriented settings focus on the VO2 max number and associated training zones. Results are generally reviewed in a follow-up consultation that translates the score into a percentile for age and sex and into specific training recommendations, with retesting typically recommended every six to twelve months. Atlas linkage for this modality is currently zero because clinic descriptions use generic language such as performance assessment or longevity testing rather than naming VO2 max or CPET explicitly. Links to performance-longevity providers such as Early Medical, Limitless Human, The Apeiron Center, and Wild Health are expected to be added manually at build.
History and background
Cardiopulmonary exercise testing and VO2 max measurement developed through exercise physiology research from the mid-twentieth century onward, with Kenneth Cooper's Cooper Clinic in Dallas, founded in 1970, generating one of the field's most influential long-running cohorts linking measured fitness to long-term health outcomes. Subsequent large-cohort studies through the 2000s and 2010s extended and replicated these findings across larger and more diverse populations, consistently reproducing VO2 max's strong association with all-cause mortality. The metric's adoption as a consumer-facing longevity marker is more recent, gaining particular visibility through physician Peter Attia, who has popularized VO2 max as a primary target metric in his public writing and clinical framework, helping move CPET from a specialized cardiopulmonary diagnostic tool into a mainstream longevity assessment.
Worth knowing
Some large-cohort analyses have found the gap in mortality risk between the lowest and highest VO2 max categories to be larger than the gap associated with smoking, a finding frequently cited in longevity medicine circles to argue that cardiorespiratory fitness deserves the same clinical attention as established risk factors. VO2 max is also one of the more tractable longevity biomarkers: it can be meaningfully improved through targeted aerobic training in people of any age, including older adults, which distinguishes it from genetic risk markers that are informative but not modifiable. Atlas linkage is currently zero due to generic-language labeling in provider descriptions, not an absence of providers offering the test.
Related modalities